Structural and pharmacological profile of generic enoxaparins used in Brazil

Lima, MA; de Farias, EHC; Gray, A; Sadeghi, N; Gesteira, TF; Cavalheiro, RP; Hoppensteadt, D; Fareed, J; Sassaki, GL; Nader, HB

doi:10.1177/1076029611426870

All Outputs (3)

Glycosaminoglycan backbone is not required for the modulation of hemostasis: Effect of different heparin derivatives and non-glycosaminoglycan analogs (2012)
Journal Article
Bouças, R., Jarrouge-Bouças, T., Lima, M., Trindade, E., Moraes, F., Cavalheiro, R., Tersariol, I., Hoppenstead, D., Fareed, J., & Nader, H. (2012). Glycosaminoglycan backbone is not required for the modulation of hemostasis: Effect of different heparin derivatives and non-glycosaminoglycan analogs. Matrix Biology, 31, 308--316. https://doi.org/10.1016/j.matbio.2012.03.001

Lepstospira interrogans shotgun phage display identified LigB as a heparin-binding protein (2012)
Journal Article
Ching, A., Fávaro, R., Lima, S., Chaves, A., de Lima, M., Nader, H., Abreu, P., & Ho, P. (2012). Lepstospira interrogans shotgun phage display identified LigB as a heparin-binding protein. Biochemical and Biophysical Research Communications, 427, 774--779. https://doi.org/10.1016/j.bbrc.2012.09.137

Structural and pharmacological profile of generic enoxaparins used in Brazil (2012)
Journal Article
Lima, M., de Farias, E., Gray, A., Sadeghi, N., Gesteira, T., Cavalheiro, R., Hoppensteadt, D., Fareed, J., Sassaki, G., & Nader, H. (2012). Structural and pharmacological profile of generic enoxaparins used in Brazil. Clinical and Applied Thrombosis/Hemostasis, 18, 379--386. https://doi.org/10.1177/1076029611426870